A clinical study on plasma biomarkers for deciding the use of adjuvant corticosteroid therapy in bronchopulmonary dysplasia of premature infants.

MLA

Zhu, Haiyan, et al. “A Clinical Study on Plasma Biomarkers for Deciding the Use of Adjuvant Corticosteroid Therapy in Bronchopulmonary Dysplasia of Premature Infants.” International Journal of Medical Sciences, vol. 18, no. 12, Apr. 2021, pp. 2581–88. EBSCOhost, https://doi.org/10.7150/ijms.58650.

APA

Zhu, H., Tian, Y., Cheng, H., Zheng, Y., Wang, W., Bao, T., Wu, R., & Tian, Z. (2021). A clinical study on plasma biomarkers for deciding the use of adjuvant corticosteroid therapy in bronchopulmonary dysplasia of premature infants. International Journal of Medical Sciences, 18(12), 2581–2588. https://doi.org/10.7150/ijms.58650

Chicago

Zhu, Haiyan, Yian Tian, Huaiping Cheng, Yafei Zheng, Wei Wang, Tianping Bao, Rong Wu, and Zhaofang Tian. 2021. “A Clinical Study on Plasma Biomarkers for Deciding the Use of Adjuvant Corticosteroid Therapy in Bronchopulmonary Dysplasia of Premature Infants.” International Journal of Medical Sciences 18 (12): 2581–88. doi:10.7150/ijms.58650.